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Streptomyces albus G serine f-lactamase
Probing of the catalytic mechanism via molecular modelling of mutant enzymes
Josette LAMOTTE-BRASSEUR, Francoise JACOB-DUBUISSON, Georges DIVE, Jean-Marie FRERE
and Jean-Marie GHUYSEN
Centre d'Ingenierie des Proteines, Universite de Liege, Institut de Chimie, B6, B-4000 Sart tilman (Liege 1), Belgium
In previous studies, several amino acids of the active site of class A ,6-lactamases have been modified by site-directed
mutagenesis. On the basis of the catalytic mechanism proposed for the Streptomyces albus G ,J-lactamase [Lamotte-
Brasseur, Dive, Dideberg, Charlier, Frere & Ghuysen (1991) Biochem. J. 279, 213-221], the influence that these mutations
exert on the hydrogen-bonding network of the active site has been analysed by molecular mechanics. The results
satisfactorily explain the effects of the mutations on the kinetic parameters of the enzyme's activity towards a set of
substrates. The present study also shows that, upon binding a properly structured ,J-lactam compound, the impaired
cavity of a mutant enzyme can readopt a functional hydrogen-bonding-network configuration.
INTRODUCTION
The serine ,-lactamases of classes A, C and D hydrolyse the ,-
lactam antibiotics by an acylation-deacylation mechanism. Sev-
eral fl-lactamases of class A have been studied by X-ray crys-
tallography (Dideberg et al., 1987; Herzberg & Moult, 1987;
Moews et al., 1990; Herzberg, 1991). They have almost com-
pletely superimposable three-dimensional structures. Their active
site is located at the junction between an all-a domain and an a/,/
domain which consists of a five-stranded f-sheet with additional
helices on both faces (Ghuysen, 1991).
The structure of the class A Streptomyces albus G ,J-lactamase
has been resolved to 0.17 nm (1.7 A) and optimized by energy
minimization (Dideberg et al., 1987; Lamotte-Brasseur et al.,
1991). The active site is a dense hydrogen-bonding network in
which nine amino acids, namely S70, K73, S130, N132, E166,
N170, K234, T235 and A237, and two water molecules, WI and
W2, are involved. The S70VFK73 motif, where S70 is the
nucleophilic serine residue, on a2 of the all-a domain, occupies
a central position in the cavity; the E166PELN170 motif, on a
loop between a6 and a8 of the all-a domain, is at the entrance of
the cavity; the S130DN1 32 motif, between a4 and a5 of the all-
a domain, lies on one side of the cavity; the K234T235GA237
motif, on the innermost /33 strand of the a/fl domain, forms the
other side.
On the basis of these structural data, molecular-mechanics
studies have allowed us to propose a mechanism of proton
abstraction-donation during hydrolysis of benzylpenicillin by
the Streptomyces albus G /3-lactamase (Lamotte-Brasseur et al.,
1991). The same procedure has now been used to study the
changes in the enzyme-ligand interactions resulting from changes
in amino acids to which a role has been assigned in catalysis. As
shown below, the rearrangements undergone by the active-site
hydrogen-bonding network are compatible with the effects that
these mutations have on the second order-rate constant for the
acylation of the essential serine residue, characterized by the
kcat./Km ratio.
MATERIALS AND METHODS
The active site of the Streptomyces albus G /,-lactamase,
defined by all the amino acids and water molecules present
0
within a 1.5 nm (15 A) radius around S7OCa, was optimized by
energy minimization (Lamotte-Brasseur et al., 1991) using the
Amber molecular-mechanics V3 framework (Weiner et al., 1984).
As an initial guess for optimization, the torsion angles of the
wild-type active site were retained as much as possible to simulate
the amino acid changes in the mutant enzymes. Minimization of
the structures was carried out until the root-mean-square gradient
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Fig. 1. (a) Arbitrary numbering of benzylpenicilHin used in the present
study, (b) optimized structures of benzylpenicilin, 6-APA and
mecillinam, and (c) standard chemical numbering of penicillins
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ated by a Monte Carlo bath (using the Amber procedure) and
their co-ordinates were minimized together with the enzyme-
mutant co-ordinates.
The structures of benzylpenicillin, 6-aminopenicillanate (6-
APA) and mecillinam, used as ligands, were optimized (Fig. 1) by
the AM I quantum-chemistry method (Dewar et al., 1985). Each
optimized molecule was docked in the cavity of the wild-type and
mutant fi-lactamases. The ,-lactam carbonyl carbon C-i was
placed close to the O-y of S70 and the oxygen atoms 0-3 and 0-
4 of the carboxylate were oriented towards the bottom of the
cavity, i.e. K234. The structures of the Michaelis complexes and,
in one case, of the tetrahedral intermediate leading to enzyme
acylation, were optimized as described for the wild-type enzyme,
using CNDO charges on the ligand. The bond lengths, bond
angles and ring dihedral angles of the fl-lactam ligands were
constrained to the AMI values.
RESULTS
The atom numbering of the/,-lactam ligands is arbitrary (see
Fig. 1). The amino acids numbering of the wild-type Streptomyces
/I-lactamase and the enzyme mutants is that described by Ambler
et al. (1991).
Selected fl-lactamase mutants
The goal of the present study was to seek an answer to
questions regarding the relationships between the alterations in
the activity of the Streptomyces albus G fi-lactamase caused by
single amino acid changes and the modifications that these
amino acid changes induce in the configuration of the hydrogen-
bonding network of the enzyme cavity.
Benzylpenicillin binds to the active site of the wild-type /?-
lactamase (Fig. 2) via formation of hydrogen bonds between:
0-3 of penicillin and the y-OH of SI 30; 0-4 of penicillin and the
y-OH of T235; 0- I of penicillin and the backbone NH groups of
S70 and A237; N2-H of penicillin and the backbone carbonyl
group of A237; and 0-2 of penicillin and the side-chain NH2
Fig. 2. Diagram of the hydrogen-bonding network of theMichaelis complex
formed between benzylpenicillin and the active site of the wild-type
S. albus G 8-lactamase
group of N132. Formation of the Michaelis complex has no or
little effect on the pre-existing hydrogen-bonding network of the
ligand-free active site, except that the hydrogen atom of SI3OyOH
no longer interacts with W2, but is oriented towards N-1 of
penicillin [as shown in Fig. 2; 0.311 nm (3.11 A); 168.5°1. The
Michaelis complex has other remarkable features. The oxygen
atom of S700yOH is 0.28 nm (2.8 A) from C-I of penicillin; the
angle C/i-Oy (of S70)... C-I (of penicillin) is 1080; the hydrogen
atom of S7OyOH is in interaction with OeiE166 via WI (the
triad S700yH-.WIH-..0eIE166) and, more loosely, with
Oe2E1 66. Hence the conditions are fulfilled to allow: proton
abstraction of the S7OyOH by Oel E1 66 via Wl; attack of C-I of
penicillin by O-y of S70; polarization of C- 1=0-1 of penicillin
located in the oxyanion hole formed by the backbone NH groups
of S70 and A237; and proton back-delivery to N-I of penicillin
by the W2, NCK73, NMK234 and Sl3OyOH hydrogen-bonding
subnetworks, thus achieving formation of the serine-ester-linked
penicilloyl-enzyme.
From the foregoing it follows that the El 66D mutation affects
the presumed proton abstractor, whereas the S130G, S130A,
N132S and K73R mutations affect, one way or another, the
presumed machinery of proton transfer from E166 to S130. The
hydrogen-bonding rearrangements induced by these mutations
(in the ligand-free active sites and Michaelis complexes) are
expressed in terms ofX... H bond distances and YH ... X bond-
angle values (X and Y are heteroatoms) in Tables 1 and 2. These
rearrangements, especially the fate of W1 and W2, are briefly
described in the ensuing sections. They are illustrated in Figs.
3-7. A 0.25 nm (2.5 A) distance is regarded as the upper limit for
a hydrogen bond.
The effects caused by the selected mutations on the enzyme
activity are expressed in terms of kcat/Km values (Table 3). It is
assumed that the K73R and E166D mutations have effects on the
Streptomyces ,/-lactamase comparable with those for the highly
homologous,-lactamase I of Bacillus cereus 569/H (Gibson et
al., 1990), whose assumed catalytic residues are conserved, except
for T235, which is replaced by S235. The kcat./Km values(equivalent to the second-order rate constant of enzyme acyl-
ation) show that the S130A and K73R mutations and, to a still
greater extent, the El 66D mutation, are profoundly detrimental,
irrespective of the /J-lactam ligand used (benzylpenicillin or 6-
APA). The Si 30G and Ni 32S mutations decrease selectively the
enzyme activity towards 6-APA (to various extents, the S130G
mutation being more deleterious than the Ni 32S mutation), but
do not affect significantly the activity towards benzylpenicillin.
Wild-type f-lactamase
Unlike benzylpenicillin, 6-APA and mecillinam have no exo-
cyclic amide bond (Fig. 1). Thereby binding of 6-APA and
mecillinam to the wild-type /-lactamase active site generates
Michaelis complexes that lack the bond NI32N8H. 0-2 (in the
case of 6-APA) and bonds N132N8H ...O0-2 and N2-H- --
O=CA237 (in the case of mecillinam). Apart from the fact that
these bonds are absent, the hydrogen-bonding networks have
features comparable with those found in the Michaelis complex
formed with benzylpenicillin (Fig. 2; Table 1, rows 1-4). Con-
sistently, benzylpenicillin, 6-APA and mecillinam have almost
identical substrate activity (kcat./Km 3000 mM-.
S130G andS130A enzyme mutants
In the wild-type enzyme, the S130C=O interacts via W2 with
the side-chain carbonyl group ofN 132 (Fig. 2), and the S 30OyOH
is thought to be involved in proton back-donation. Hence the
S130G and S130A mutations are expected to eliminate the
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Table 2. X... H distances and YH.... X bond angles (X and Y are
heterotoms) of hydrogen bonds around R73 within the active site
of the K73R Streptomyces albus G Ii-lactamase mutant and the
Michaelis complex formed with benzylpenicillin (' +pen')
Bond distance (A; note 1 AnO.I nm)
or bond angle (0)
R73N,12
R73Ne R73N 1
Enzyme or H ... H... H1 H2...
Michaelis
complex Oe1E166 OyS130 Oe1E166 OWN132 OyS70
K73R 1.707 1.707 1.72 2.176 3.007
144.8 155.0 141.8 110.0 100.4
+pen 1.759 1.688 1.679 2.327 1.784
144.2 158.4 146.1 101.6 134.8
Table 3. Catalytic efficiency (kcatl/Km) of the S. albus G and B. cereus wild-
type /I-lactamases and fi-lactamase mutants
The catalytic-centre activities of the Streptomyces and Bacillus
wild-type fl-lactamases are identical with respect to benzylpenicillin
(kcat 2800 s-1 as against 2200 s-1) and of the same order of
magnitude with respect to 6-APA (720 s-' as against 260 s-'). The
differences in the kcat /Km values are mainly due to differences in the
Km values. Results for S. albus G are from Jacob et al. (1990a,b);
those for B. cereus are from Gibson et al. (1990).
kcat./Km (mM1
Enzyme Substrate ... Benzylpenicillin 6-APA Mecillinam
S. albus G
Wild-type 2800 3700 2600
S13OG 480 4
S130A 70 3





proton donor and to perturb the W2 hydrogen-bonding sub-
network.
Molecular modelling of the S130G mutant enzyme (Figs. 3a
and 3b; Table 1, row 5) shows that W2 still closely interacts with
ON132 and forms a W2H... O=CG1 30 bond (similar to the
W2H... O=CS130 bond in the wild-type enzyme), but W2 is
displaced 0.29 nm (2.9 A) towards the G130DN132 motif. Re-
placement of S130 by G also affects the WI subnetwork.
Though still closely interacting with O01 E166, WI is disconnected
from Oe2E 166 and O0N 170 as well as from S700y, thus damaging
the S700yH-.WlH-*OelE166 proton-abstractor triad.
Molecular modelling of the S130A mutant enzyme (Figs.
4a and 4b; Table 1, row 8) shows that the triad S700yH-+
WlH-.c0E166 remains as strongly hydrogen-bonded
as it is in the wild-type enzyme but, as a result of the steric
effect of the Al 30 methyl group, W2 is displaced 0.14 nm
(1.4 A) so that it forms, with N132 and WI, a strongly hydrogen-
bonded N13280 . HW2H W I triad.
Docking 6-APA in the cavity of both mutant enzymes leads to
optimized structures in which the configuration of the proton-
abstractor machinery (Table 1, rows 7 and 10) remains in-
compatible with any significant catalytic activity.
By contrast, docking benzylpenicillin in the active site of the
S13OG mutant enzyme shows that, in the Michaelis complex, a
strongly hydrogen-bonded S70OyH-+WlH-.Oe1E166 triad is
reformed (Fig. 3c; Table 1, row 6). Moreover, in the tetrahedral
intermediate, W2 undergoes such a displacement that it is located
at approximately the same position as that occupied by SI3OyOH
in the wild-type enzyme and has one of its hydrogen atoms
oriented towards N-I of penicillin (Fig. 3d). These induced
configuration changes are probably able to restore a functional
proton-abstraction-donation network, though its configuration
differs, at least in part, from that of the wild-type fl-lactamase.
With reference to the wild-type enzyme, the S13OG mutant
enzyme hydrolyses benzylpenicillin effectively, with a 6-fold-
decreased kcat./Km value.
Conversely, the presence of the additional methyl group in the
S130A mutant results in a less efficient positioning of the W2
molecule, explaining an additional decrease of the rate of
acylation by benzylpenicillin.
N132S mutant enzyme
Changing N132 is another way to perturb the
S130C=O... HW2H... ONN132 triad and, as a consequence of
this, the W2 and WI hydrogen-bonding subnetworks. Modelling
of the N132S mutant enzyme (Figs. 5a and 5b; Table 1, row 11)
shows that W2 is in interaction with O=CS130 (as in the wild-
type enzyme), but not with OyS132, and that WI is in interaction
with Oe1E166 (as in the wild-type enzyme), but not with S700y.
Docking benzylpenicillin (Fig. Sc; Table 1, row 12) and mecil-
linam (Fig. 5d; Table 1, row 14) in the mutant enzyme generates
Michaelis complexes whose WI and W2 hydrogen-bonding
subnetworks re-adopt a configuration similar to that formed in
the benzylpenicillin-, or mecillinam-, wild-type-enzyme Michaelis
complex. 6-APA (Table 1, row 13), however, fails to restore a
functional configuration. These observations are consistent with
the data of Table 3.
K73R mutant enzyme
In the wild type fl-lactamase, K73NC is central to the W2-W1
hydrogen-bonding subnetworks through the bonds that it forms
with O=CS130, O0N132, OeE166 and OyS70 (Fig. 2; Table 1,
row 1). Replacement of K73 by R73 perturbs the original
configuration (Fig. 6a and 6b; Table 1, row 15, and Table 2). In
the newly formed configuration, W2 still interacts with O=CS 130,
but it is connected to S13OyOH, not to ON132. WI still
interacts with S7OyOH, but it is linked much more closely to
Oe2E166 than to OeE 166. Upon benzylpenicillin binding (Table
1, row 16, and Table 2), the N13280. HW2H - O=CS 130
triad is regenerated (as it occurs in the wild-type ,1-lactamase),
but WI remains in close interaction with 0e2E166, thus pre-
venting restoration of the 'normal' S700yH-.WIH-OelEl66
proton-abstractor triad. Consistently the K73R mutant enzyme
has a very weak activity towards benzylpenicillin.
E166D mutant enzyme
Shortening the side chain of the carboxylic acid at position
166, i.e. the proton abstractor, has drastic effects (Figs. 7a and
7b; Table 1, row 17). WI is disconnected from S7OyOH and is
hydrogen-bonded to 082DI66, not OdID166; W2 still interacts
with ON132, but it is disconnected from OySl30 and forms
with WI a hydrogen-bonded W2-H ... WI dyad. Benzylpenicillin
binding fails to regenerate a configuration compatible with
proton abstraction-donation (Table 1, row 18). The E166D
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Molecular modelling of class A fl-lactamase mutants
(a) (b)
(c)
Fig. 3. S. albus G /I-lactamase S13OG mutant
(a) Superimposition of the cavity of the mutant (black polypeptide backbone) and the active site of the wild-type enzyme (white polypeptide
backbone). Key to atoms: 0, oxygen; (, nitrogen atoms. The underlined WI and W2 belong to the mutant. (b) Diagram of the hydrogen-
bonding network of the ligand-free cavity of the mutant. (c) Michaelis complex formed with benzylpenicillin. (d) Tetrahedral intermediate leading
to penicilloylation of S70.
(a) (b)
Fig. 4. S. albus G fl-lactamase S130A mutant
(a) Superimposition of the cavity of the mutant (black polypeptide backbone) and the active site of the wild-type enzyme (white polypeptide
backbone). Key to atoms: 0, oxygen; O, nitrogen. The underlined WI and W2 belong to the mutant. (b) Diagram of the hydrogen-bonding
network of the ligand-free cavity of the mutant.
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(a) (b)
(c)
Fig. 5. S. albus G f,-lactamase N132S mutant
(a) Superimposition of the cavity of the mutant (black polypeptide backbone) and the active site of the wild-type enzyme (white polypeptide
backbone) Key to atoms: 0, oxygen; @, nitrogen. The underlined W1 and W2 belong to the mutant. (b) Diagram of the hydrogen-bonding
network of the ligand-free cavity of the mutant. (c) Michaelis complex formed with benzylpenicillin. (d) Michaelis complex formed with
mecillinam.
(a) (b)
Fig. 6. S. albus-G fi-lactamase K73R mutant
(a) Superimposition of the cavity of the mutant (black polypeptide backbone) and the active site of the wild-type enzyme (white polypeptide
backbone). Key to atoms: 0, oxygen; O, nitrogen. The underlined WI and W2 belong to the mutant. (b) Diagram of the hydrogen-bonding
network of the ligand-free cavity of the mutant.
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Molecular modelling of class A ,1-lactamase mutants
(a) (b)
Fig. 7. S. albus G II-lactamase E166D mutant
(a) Superimposition of the cavity of the mutant (black polypeptide backbone) and the active site of the wild-type enzyme (white polypeptide
backbone). Key to atoms: 0, oxygen; 0, nitrogen. The underlined WI and W2 belong to the mutant. (b) Diagram of the hydrogen-bonding
network of the ligand-free cavity of the mutant.
mutant enzyme has a 500-fold-decreased kcat /Km value with
respect to benzylpenicillin.
DISCUSSION
It has been proposed (Lamotte-Brasseur et al., 1991) that three
amino acids, namely S70, E166 and S130, and two water
molecules, W1 and W2, are central to the Streptomyces albus G
,/-lactamase-catalysed hydrolysis of penicillin. WI transfers the
proton from S7OyOH to the abstractor OIE 166, allowing attack
of the carbonyl carbon atom of the /3-lactam ring by S700y. W2
is an integral component of the relay system through which a
proton is delivered back to the nitrogen atom of the fl-lactam
ring, via S130y0H (thus achieving rupture of the amide bond
and formation of the serine-ester-linked acyl-enzyme). To test the
mechanism, the effects of mutations affecting E166 and S130 (the
proton abstractor and a residue involved in proton donation)
and N132 and K73 (involved in the configuration of the Wl and
W2 hydrogen bonding subnetworks) have been examined by
optimizing the complexes formed by docking benzylpenicillin, 6-
APA and sometimes mecillinam in the mutated-enzyme cavities.
The observed changes induced in the hydrogen-bonding network
by each of the mutations studied well explain, at least to a first
approximation, the effects that these mutations have on the
catalytic activity of the ,J-lactamase.
The present studies also show that,. owing to the high density
of the hydrogen-bonding network, the enzyme cavity is a
structure of high plasticity both structurally and mechanistically.
Local modifications that cause the disappearance or weakening
of any hydrogen bond may propagate its effects far from the
mutated amino acid and modify the entire configuration of the
cavity. A cavity, damaged by mutation, may regain functionality
upon binding of a properly structured fl-lactam compound,
either by readopting a hydrogen-bonding configuration com-
parable with that of the wild-type enzyme or by utilizing an
alternate route of proton shuttle from El 66 to the nitrogen atom
of the fl-lactam ring. To all appearances, however, an intact,
strongly hydrogen-bonded S70y0H-+WlH-.O01E166 triad is
essential to the catalytic mechanism.
Adaptation of the ,1-lactamases to the environmental condi-
tions is well documented. ,?-Lactamases show hysteretic kinetics.
A unique conformation is induced in the enzymes by each of
several closely related ,-lactam substrates, and the enzymes can
adjust to unfavourable modifications in the substrate (Samuni &
Citri, 1979).
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